Oculis Holding AG (OCS) Payables (2021 - 2026)
Oculis Holding AG (OCS) recorded quarterly Payables of $5.7 million in Q1 2026, up 154.94% quarter-over-quarter from $2.3 million in Q4 2025, and up 18.64% on a YoY basis from $4.8 million in Q1 2025.
Oculis Holding AG (OCS) Payables (2021 - 2026) Analysis & Trends
Oculis Holding AG's Payables history runs 6 years deep, the most recent figure standing at $5.7 million for Q1 2026.
- In Q1 2026, Payables rose 18.64% year-over-year to $5.7 million; the TTM figure through Mar 2026 stood at $5.7 million (up 18.64% YoY), while the FY2025 annual figure was $2.3 million, down 66.4% from the prior year.
- Payables was $5.7 million for Q1 2026 at Oculis Holding AG, up from $2.3 million in the prior quarter.
- In the past five years, Payables ranged from a high of $8.6 million in Q4 2023 to a low of $1.3 million in Q1 2024.
- Historically, Payables has averaged $4.4 million across 5 years, with a median of $4.4 million in 2023.
- The sharpest annual moves came in 2022 and 2025: Payables soared 349.18% in 2022, then slumped 72.97% in 2025.
- A 5-year view of Payables shows it stood at $4.0 million in 2022, then surged by 113.34% to $8.6 million in 2023, then declined by 21.74% to $6.7 million in 2024, then plunged by 66.4% to $2.3 million in 2025, then jumped by 154.94% to $5.7 million in 2026.
- The last three Payables figures came in at $5.7 million (Q1 2026), $2.3 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 8.69 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 34.55 Mn |
| 10 | Oculis Holding AG | 8.23 Bn | 7.92 Bn | - | 5.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.74 Mn |
| Dec 31, 2025 | 2.25 Mn |
| Sep 30, 2025 | 1.53 Mn |
| Jun 30, 2025 | 1.45 Mn |
| Mar 31, 2025 | 4.84 Mn |
| Dec 31, 2024 | 6.70 Mn |
| Sep 30, 2024 | 5.65 Mn |
| Jun 30, 2024 | 3.52 Mn |
| Mar 31, 2024 | 1.35 Mn |
| Dec 31, 2023 | 8.56 Mn |
| Sep 30, 2023 | 7.60 Mn |
| Jun 30, 2023 | 4.36 Mn |
| Dec 31, 2022 | 4.01 Mn |
| Dec 31, 2021 | 893,629.73 |